Be Clinical raises Rs 21 Cr in Seed Round to expand skincare portfolio

Be Clinical, an evidence-led skincare brand focused on clinically effective solutions for ageing skin, has raised Rs 21 crore in its Seed round, led by Sauce. The round also saw participation from V3 Ventures (Verlinvest SA) and a group of angel investors, including Mokobara founders Sangeet Agrawal and Navin Parwal; Arjun Purkayastha, SVP & Managing Director for Greater China & North Asia at Reckitt; and Shaunak Chirayu Amin.

Founded by Hemangi Dhir and launched in May 2025 after two years of research and development, Delhi-based startup Be Clinical is building a skincare brand built around clinically tested formulations, dermatologically active ingredients and an evidence-led approach to addressing ageing concerns.

The brand’s products are developed specifically with Indian skin and conditions in mind, with clinical testing undertaken to validate safety and efficacy before products reach consumers. The brand, through its in-house manufacturing, occupies control over the quality and efficacy of its products.

The funds raised will be used to support Be Clinical’s next phase of growth, with a focus on product innovation and portfolio expansion. The capital will strengthen research and development capabilities, expand the clinical skincare range, scale manufacturing capacity to meet growing demand, and support expansion into new markets and geographies.

The company’s focus will remain on developing clinically tested, transparent and effective skincare solutions that address ageing concerns, while making science-backed skincare more accessible to Indian consumers.